marketcaparena
Search

    SRTA

    Strata Critical Medical, Inc.

    Company overview

    Market capitalization
    $462.68M
    Employees
    327
    Latest publication
    2026-09-29
    About Strata Critical Medical, Inc.

    Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20212021-03-31 · USDQ3 20202020-09-30 · USDQ1 20202020-03-31 · USDQ3 20192019-09-30 · USD
    Total Revenue72,506,000USD9,273,000USD8,319,000USD——
    Cost Of Revenue57,291,000USD7,673,000USD6,715,000USD—43,053USD
    Gross Profit15,215,000USD1,600,000USD1,604,000USD—-43,053USD
    Selling General Administrative13,996,000USD4,803,000USD1,916,000USD145,130USD43,053USD
    Other Operating Expenses6,627,000USD——145,130USD43,053USD
    Total Operating Expenses20,623,000USD235,113USD2,335,000USD145,130USD43,053USD
    Operating Income-5,408,000USD-235,113USD-731,000USD-145,130USD125,227USD
    Total Other Income Expense Net-5,108,000USD-845,865USD18,000USD869,270USD168,280USD
    Income Before Tax-10,516,000USD-1,080,978USD-713,000USD724,140USD125,227USD
    Income Tax Expense0USD845,865USD-26,624USD152,069USD26,088USD
    Discontinued Operations0USD————
    Net Income-10,516,000USD-1,080,978USD-713,000USD572,071USD99,139USD
    Research Development—156,000USD170,000USD——
    Unclassified Operating Expenses—-4,723,887USD———
    Ebit—-3,379,135USD-731,000USD-145,130USD125,227USD
    Ebitda—-235,113USD-603,000USD724,140USD-81,874,773USD
    Depreciation And Amortization—-845,865USD128,000USD869,270USD-82,000,000USD
    Selling And Marketing Expenses——249,000USD——
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets332,698,000USD327,618,000USD325,472,000USD335,078,000USD257,918,999USD250,550,000USD256,675,000USD282,945,000USD
    Total Current Assets121,010,000USD124,145,000USD126,192,000USD122,482,000USD156,480,000USD152,312,000USD160,742,000USD171,760,000USD
    Other Current Assets54,586,000USD25,754,000USD25,003,000USD9,026,000USD14,888,000USD10,178,000USD12,016,000USD10,941,000USD
    Other Non Current Assets90,000USD———————
    Total Liabilities53,380,000USD———————
    Total Current Liabilities45,779,000USD20,942,000USD19,794,000USD27,874,000USD26,312,000USD21,881,000USD22,726,000USD27,181,000USD
    Other Current Liabilities26,344,000USD———————
    Other Non Current Liabilities4,129,000USD———————
    Total Stockholder Equity279,318,000USD285,731,000USD279,072,000USD283,000,000USD223,100,000USD219,732,000USD221,938,000USD233,499,000USD
    Total Equity Including Noncontrolling Interest279,318,000USD———————
    Net Receivables43,407,000USD39,602,000USD39,958,000USD37,538,000USD28,172,000USD22,128,000USD21,591,000USD24,481,000USD
    Property Plant Equipment Net44,644,000USD44,282,000USD39,551,000USD41,835,000USD42,150,000USD41,218,000USD39,794,000USD53,363,000USD
    Goodwill106,946,000USD———————
    Intangible Assets60,008,000USD46,312,000USD47,502,000USD49,754,000USD13,580,000USD13,528,000USD13,653,000USD13,957,000USD
    Accounts Payable18,381,000USD19,955,000USD—27,220,000USD13,679,000USD———
    Short Term Debt1,054,000USD987,000USD652,000USD654,000USD3,521,000USD3,362,000USD3,304,000USD4,472,000USD
    Common Stock7,000USD7,000USD7,000USD7,000USD7,000USD7,000USD7,000USD7,000USD
    Retained Earnings-153,913,000USD-143,397,000USD-145,551,000USD-136,718,000USD-194,134,000USD-190,391,000USD-186,898,000USD-177,105,000USD
    Accumulated Other Comprehensive Income0USD——0USD5,967,999USD3,069,000USD1,753,000USD4,173,000USD
    Total Liab—41,887,000USD46,400,000USD52,078,000USD34,818,999USD30,818,000USD34,737,000USD49,446,000USD
    Other Current Liab—19,955,000USD19,142,000USD27,220,000USD9,112,000USD10,505,000USD12,766,000USD16,028,000USD
    Capital Stock—7,000USD7,000USD7,000USD7,000USD7,000USD7,000USD7,000USD
    Good Will—88,589,000USD88,210,000USD84,607,000USD44,251,000USD42,038,000USD41,050,000USD42,952,000USD
    Cash—58,723,000USD30,968,000USD22,753,000USD58,754,000USD34,830,000USD18,378,000USD20,028,000USD
    Cash And Short Term Investments—58,789,000USD61,231,000USD75,918,000USD113,420,000USD120,006,000USD127,135,000USD136,338,000USD
    Net Debt—-54,255,000USD-27,661,000USD-19,282,000USD-49,915,000USD-25,762,000USD-9,056,000USD3,715,000USD
    Short Long Term Debt Total—4,468,000USD3,307,000USD3,471,000USD8,839,000USD9,068,000USD9,322,000USD23,743,000USD
    Short Term Investments—66,000USD30,263,000USD53,165,000USD54,666,000USD85,176,000USD108,757,000USD116,310,000USD
    Property Plant Equipment Gross—52,142,000USD45,837,000USD46,778,000USD49,238,000USD47,529,000USD45,091,000USD57,760,000USD
    Common Stock Shares Outstanding—90,168,853shares82,454,657shares82,454,657shares81,297,402shares79,891,829shares79,419,000shares78,044,254shares
    Non Current Assets Total—203,473,000USD199,280,000USD212,596,000USD101,438,999USD98,238,000USD95,933,000USD111,185,000USD
    Non Current Liabilities Total—20,945,000USD26,606,000USD24,204,000USD8,506,999USD8,937,000USD12,011,000USD22,265,000USD
    Non Current Liabilities Other—17,122,000USD22,073,000USD18,260,000USD————
    Non Currrent Assets Other—24,290,000USD24,017,000USD36,400,000USD1,457,999USD1,454,000USD1,436,000USD913,000USD
    Net Working Capital—103,203,000USD106,398,000USD94,608,000USD130,168,000USD130,431,000USD138,016,000USD144,579,000USD
    Unclassified Current Liabilities—-19,955,000USD—-27,220,000USD-9,112,000USD———
    Unclassified Non Current Liabilities—3,823,000USD4,533,000USD5,944,000USD8,506,999USD8,937,000USD12,011,000USD22,265,000USD
    Unclassified Equity—429,114,000USD424,609,000USD419,704,000USD411,252,001USD407,040,000USD407,069,000USD406,417,000USD
    Current Deferred Revenue————9,112,000USD8,014,000USD6,656,000USD6,681,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Total Assets325,472,000USD256,675,000USD294,938,000USD325,025,000USD335,884,000USD17,715,000USD277,692,204USD
    Intangible Assets47,502,000USD13,653,000USD20,519,000USD46,365,000USD24,421,000USD533,000USD—
    Other Current Assets25,003,000USD12,016,000USD19,119,000USD15,171,000USD6,881,000USD613,000USD-276,136,596USD
    Total Liab46,400,000USD34,737,000USD60,638,000USD50,536,000USD44,513,000USD6,635,000USD272,692,196USD
    Total Stockholder Equity279,072,000USD221,938,000USD234,300,000USD274,489,000USD291,371,000USD11,080,000USD5,000,008USD
    Other Current Liab19,142,000USD12,766,000USD23,859,000USD6,709,000USD5,976,000USD3,973,000USD-68,672USD
    Common Stock7,000USD7,000USD7,000USD7,000USD7,000USD3,000USD132USD
    Capital Stock7,000USD7,000USD7,000USD7,000USD7,000USD——
    Retained Earnings-145,551,000USD-186,898,000USD-159,754,000USD-103,678,000USD-76,418,000USD-37,138,000USD784,778USD
    Good Will88,210,000USD41,050,000USD40,373,000USD39,445,000USD13,328,000USD——
    Cash30,968,000USD18,378,000USD27,873,000USD41,338,000USD2,595,000USD12,162,000USD1,305,608USD
    Cash And Short Term Investments61,231,000USD127,135,000USD166,137,000USD192,078,000USD281,969,000USD12,162,000USD277,567,204USD
    Total Current Assets126,192,000USD160,742,000USD206,261,000USD218,126,000USD294,945,000USD14,379,000USD1,430,608USD
    Total Current Liabilities19,794,000USD22,726,000USD35,491,000USD26,607,000USD12,783,000USD6,344,000USD371,306USD
    Net Debt-27,661,000USD-9,056,000USD-3,348,000USD-23,006,000USD-1,879,000USD-10,276,000USD-842,876USD
    Short Term Debt652,000USD3,304,000USD4,787,000USD3,362,000USD438,000USD1,595,000USD231,366USD
    Short Long Term Debt Total3,307,000USD9,322,000USD24,525,000USD18,332,000USD716,000USD1,886,000USD462,732USD
    Short Term Investments30,263,000USD108,757,000USD138,264,000USD150,740,000USD279,374,000USD—276,261,596USD
    Net Receivables39,958,000USD21,591,000USD21,005,000USD10,877,000USD5,548,000USD1,092,000USD—
    Accounts Payable19,142,000USD——16,536,000USD6,369,000USD776,000USD—
    Property Plant Equipment Net39,551,000USD39,794,000USD26,383,000USD19,729,000USD2,758,000USD2,496,000USD—
    Property Plant Equipment Gross45,837,000USD45,091,000USD29,538,000USD21,963,000USD4,335,000USD——
    Common Stock Shares Outstanding82,454,657shares77,499,423shares73,524,476shares71,238,103shares70,096,401shares12,512,567shares7,358,679shares
    Non Current Assets Total199,280,000USD95,933,000USD88,677,000USD106,899,000USD40,939,000USD3,336,000USD276,261,596USD
    Non Current Liabilities Total26,606,000USD12,011,000USD25,147,000USD23,929,000USD31,730,000USD291,000USD231,366USD
    Non Current Liabilities Other22,073,000USD——————
    Non Currrent Assets Other24,017,000USD1,436,000USD1,402,000USD1,360,000USD232,000USD107,000USD—
    Net Working Capital106,398,000USD138,016,000USD170,770,000USD191,519,000USD282,162,000USD——
    Unclassified Current Liabilities-19,142,000USD——-6,709,000USD-5,976,000USD-3,973,000USD—
    Unclassified Non Current Liabilities4,533,000USD12,011,000USD25,147,000USD23,929,000USD31,730,000USD——
    Unclassified Equity424,609,000USD407,069,000USD390,076,000USD375,866,001USD368,673,000USD48,215,000USD4,215,098USD
    Current Deferred Revenue—6,656,000USD6,845,000USD6,709,000USD5,976,000USD3,973,000USD—
    Accumulated Other Comprehensive Income—1,753,000USD3,964,000USD2,286,999USD-898,000USD0USD—
    Long Term Investments———390,000USD200,000USD——
    Inventory———1,127,000USD547,000USD512,000USD—
    Unclassified Current Assets——————-276,136,596USD
    Unclassified Non Current Assets——————276,261,596USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income2,402,000USD-8,833,000USD-9,657,000USD-3,743,000USD-3,493,000USD-9,793,000USD-1,954,000USD-11,326,000USD
    Depreciation3,060,000USD3,008,000USD1,445,000USD1,776,000USD1,697,000USD1,530,000USD1,279,000USD1,559,000USD
    Stock Based Compensation5,035,000USD6,586,000USD5,119,000USD5,349,000USD4,217,000USD4,526,000USD5,402,000USD5,647,000USD
    Other Non Cash Items-339,000USD2,917,000USD-32,169,000USD-434,000USD-3,475,000USD8,151,000USD-590,000USD10,560,000USD
    Change To Account Receivables149,000USD-3,483,000USD-1,774,000USD-6,257,000USD-520,000USD2,613,000USD3,356,000USD-4,358,000USD
    Change In Working Capital-1,490,000USD-11,859,000USD7,987,000USD-6,033,000USD825,000USD230,000USD2,336,000USD6,598,000USD
    Total Cash From Operating Activities3,556,000USD-8,307,000USD-31,840,000USD-3,064,000USD-246,000USD13,000USD6,355,000USD7,443,000USD
    Capital Expenditures-5,481,000USD-2,005,000USD-3,126,000USD-2,733,000USD-3,146,000USD-5,042,000USD-9,917,000USD-16,908,000USD
    Free Cash Flow-1,925,000USD-10,312,000USD-34,966,000USD-5,797,000USD-3,392,000USD-5,029,000USD-3,562,000USD-9,465,000USD
    Investments30,500,000USD23,200,000USD2,398,000USD28,680,000USD20,407,000USD3,976,000USD-12,646,000USD-16,908,000USD
    Total Cashflows From Investing Activities24,729,000USD18,265,000USD2,398,000USD28,680,000USD20,407,000USD3,976,000USD-12,646,000USD-16,908,000USD
    Total Cash From Financing Activities-530,000USD-1,742,000USD-7,244,000USD-1,137,000USD-4,246,000USD-5,639,000USD-731,000USD-222,000USD
    Change In Cash27,755,000USD8,216,000USD-37,302,000USD24,630,000USD16,041,000USD-1,759,000USD-6,960,000USD-9,694,000USD
    Begin Period Cash Flow31,232,000USD23,016,000USD60,318,000USD35,688,000USD19,647,000USD21,406,000USD28,366,000USD38,060,000USD
    End Period Cash Flow58,987,000USD31,232,000USD23,016,000USD60,318,000USD35,688,000USD19,647,000USD21,406,000USD28,366,000USD
    Other Cashflows From Financing Activities-582,000USD-1,796,000USD-7,309,000USD-1,151,000USD-4,306,000USD-5,683,000USD-731,000USD-1,208,000USD
    Unclassified Operating Cash Flow-5,112,000USD—-4,565,000USD——-4,631,000USD—-5,595,000USD
    Sale Purchase Of Stock—0USD0USD——0USD0USD-244,000USD
    Other Cashflows From Investing Activities—-157,000USD195,306,000USD-360,000USD-532,000USD-452,000USD-2,828,000USD-745,000USD
    Unclassified Investing Cash Flow—-2,773,000USD-192,180,000USD3,093,000USD3,678,000USD5,494,000USD12,745,000USD17,653,000USD
    Unclassified Financing Cash Flow———————1,230,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Net Income41,347,000USD-27,307,000USD-56,076,000USD-27,260,000USD-40,052,000USD-10,160,000USD-10,838,000USD
    Depreciation8,185,000USD5,962,000USD7,111,000USD5,725,000USD596,000USD526,000USD472,000USD
    Stock Based Compensation17,832,000USD19,893,000USD12,501,000USD8,277,000USD9,621,000USD490,000USD317,000USD
    Other Non Cash Items-107,630,000USD2,197,000USD12,318,000USD-23,083,000USD20,062,000USD—28,000USD
    Change To Account Receivables-12,034,000USD-998,000USD-10,254,000USD-5,347,000USD-414,000USD-591,000USD-165,000USD
    Change In Working Capital-9,080,000USD-3,009,000USD-6,737,000USD-17,000USD-2,199,000USD-1,674,000USD-281,000USD
    Total Cash From Operating Activities-48,914,000USD-2,519,000USD-32,349,000USD-37,130,000USD-15,615,000USD-10,818,000USD-10,302,000USD
    Capital Expenditures-11,010,000USD-32,994,000USD-2,109,000USD-730,000USD-801,000USD-377,000USD-854,000USD
    Free Cash Flow-59,924,000USD-35,513,000USD-34,458,000USD-37,860,000USD-16,416,000USD-11,195,000USD-11,156,000USD
    Investments150,105,000USD-1,016,000USD17,089,000USD79,340,000USD-321,338,000USD——
    Total Cashflows From Investing Activities69,750,000USD-1,016,000USD17,089,000USD79,340,000USD-321,338,000USD-377,000USD-1,054,000USD
    Total Cash From Financing Activities-8,912,000USD-5,759,000USD-76,000USD-1,084,000USD332,259,000USD1,180,000USD116,000USD
    Sale Purchase Of Stock0USD-244,000USD0USD————
    Change In Cash11,585,000USD-9,374,000USD-15,402,000USD36,841,000USD-4,694,000USD-10,015,000USD-11,240,000USD
    Begin Period Cash Flow19,647,000USD29,021,000USD44,423,000USD7,582,000USD12,276,000USD22,291,000USD33,531,000USD
    End Period Cash Flow31,232,000USD19,647,000USD29,021,000USD44,423,000USD7,582,000USD12,276,000USD22,291,000USD
    Other Cashflows From Investing Activities-1,415,000USD-2,106,000USD138,000USD—-504,000USD—-250,000USD
    Other Cashflows From Financing Activities-9,105,000USD-5,515,000USD-76,000USD-1,171,000USD213,790,000USD15,000USD116,000USD
    Unclassified Investing Cash Flow-67,930,000USD35,100,000USD1,971,000USD————
    Unclassified Operating Cash Flow——-1,466,000USD—-3,643,000USD——
    Net Borrowings———0USD-1,165,000USD——
    Issuance Of Capital Stock———0USD119,634,000USD——
    Unclassified Financing Cash Flow—————1,165,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30SegmentClinical24,266,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentLogistics48,240,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31SegmentClinical19,785,000USD0001628280-26-031032
    Q1 2026Quarterly · 2026-03-31SegmentLogistics47,599,000USD0001628280-26-031032
    FY 2025Yearly · 2025-12-31SegmentClinical20,348,000USD0001628280-26-013628
    FY 2025Yearly · 2025-12-31SegmentLogistics176,793,000USD0001628280-26-013628
    Q2 2025Quarterly · 2025-06-30SegmentMedical45,108,000USD0001779128-25-000060
    Q2 2025Quarterly · 2025-06-30SegmentPassenger25,693,000USD0001779128-25-000060
    Q2 2025Quarterly · 2025-06-30GeographyInternational8,355,000USD0001779128-25-000060
    Q2 2025Quarterly · 2025-06-30GeographyUnited States62,446,000USD0001779128-25-000060
    Q1 2025Quarterly · 2025-03-31SegmentClinical0USD0001628280-26-031032
    Q1 2025Quarterly · 2025-03-31SegmentLogistics35,948,000USD0001628280-26-031032
    Q1 2025Quarterly · 2025-03-31GeographyInternational5,937,000USD0001779128-25-000042
    Q1 2025Quarterly · 2025-03-31GeographyUnited States48,369,000USD0001779128-25-000042
    Q4 2024Quarterly · 2024-12-31SegmentMedical36,388,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentPassenger17,969,000USDLegacy provider
    FY 2024Yearly · 2024-12-31SegmentClinical0USD0001628280-26-013628
    FY 2024Yearly · 2024-12-31SegmentLogistics146,817,000USD0001628280-26-013628
    Q4 2024Quarterly · 2024-12-31GeographyInternational2,193,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyUnited States52,164,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyInternational29,946,000USD0001779128-25-000010
    FY 2024Yearly · 2024-12-31GeographyUnited States218,747,000USD0001779128-25-000010
    Q3 2024Quarterly · 2024-09-30SegmentMedical36,062,000USD0001779128-24-000126
    Q3 2024Quarterly · 2024-09-30SegmentPassenger38,815,000USD0001779128-24-000126
    Q3 2024Quarterly · 2024-09-30GeographyInternational11,595,000USD0001779128-24-000126
    Q3 2024Quarterly · 2024-09-30GeographyUnited States63,282,000USD0001779128-24-000126
    Q2 2024Quarterly · 2024-06-30SegmentMedical38,341,000USD0001779128-25-000060
    Q2 2024Quarterly · 2024-06-30SegmentPassenger29,604,000USD0001779128-25-000060
    Q2 2024Quarterly · 2024-06-30GeographyInternational9,945,000USD0001779128-25-000060
    Q2 2024Quarterly · 2024-06-30GeographyUnited States58,000,000USD0001779128-25-000060
    Q1 2024Quarterly · 2024-03-31SegmentMedical36,026,000USD0001779128-25-000042
    Q1 2024Quarterly · 2024-03-31SegmentPassenger15,488,000USD0001779128-25-000042
    Q1 2024Quarterly · 2024-03-31GeographyInternational6,213,000USD0001779128-25-000042
    Q1 2024Quarterly · 2024-03-31GeographyUnited States45,301,000USD0001779128-25-000042
    FY 2023Yearly · 2023-12-31SegmentMedical126,604,000USD0001779128-25-000010
    FY 2023Yearly · 2023-12-31SegmentPassenger98,576,000USD0001779128-25-000010
    Q4 2023Quarterly · 2023-12-31GeographyInternational5,354,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31GeographyUnited States42,124,000USDLegacy provider
    FY 2023Yearly · 2023-12-31GeographyInternational34,436,000USD0001779128-25-000010
    FY 2023Yearly · 2023-12-31GeographyUnited States190,744,000USD0001779128-25-000010
    Q3 2023Quarterly · 2023-09-30GeographyInternational12,812,000USD0001779128-24-000126
    Q3 2023Quarterly · 2023-09-30GeographyUnited States58,630,000USD0001779128-24-000126
    FY 2022Yearly · 2022-12-31SegmentMedical71,779,000USD0001779128-24-000015
    FY 2022Yearly · 2022-12-31SegmentPassenger74,341,000USD0001779128-24-000015
    FY 2022Yearly · 2022-12-31GeographyInternational12,822,000USD0001779128-24-000015
    FY 2022Yearly · 2022-12-31GeographyUnited States133,298,000USD0001779128-24-000015
    Q3 2022Quarterly · 2022-09-30ProductJet And Other5,101,000USD0001779128-22-000112
    Q3 2022Quarterly · 2022-09-30ProductMedi Mobility Organ Transport And Jet20,219,000USD0001779128-22-000112
    Q3 2022Quarterly · 2022-09-30ProductShort Distance20,402,000USD0001779128-22-000112
    Q2 2022Quarterly · 2022-06-30ProductJet And Other7,421,000USD0001779128-22-000083
    Q2 2022Quarterly · 2022-06-30ProductMedi Mobility Organ Transport And Jet17,249,000USD0001779128-22-000083
    Q2 2022Quarterly · 2022-06-30ProductShort Distance10,963,000USD0001779128-22-000083
    Q1 2022Quarterly · 2022-03-31ProductMedi Mobility Organ Transport And Jet22,115,000USD0001779128-22-000047
    Q1 2022Quarterly · 2022-03-31ProductOther312,000USD0001779128-22-000047
    Q1 2022Quarterly · 2022-03-31ProductShort Distance4,203,000USD0001779128-22-000047
    FY 2021Yearly · 2021-09-30SegmentMedical6,401,000USD0001779128-23-000029
    FY 2021Yearly · 2021-09-30SegmentPassenger44,125,000USD0001779128-23-000029
    FY 2021Yearly · 2021-09-30GeographyInternational0USD0001779128-23-000029
    FY 2021Yearly · 2021-09-30GeographyUnited States50,526,000USD0001779128-23-000029
    Q3 2021Quarterly · 2021-09-30ProductJet And Other4,668,000USD0001779128-22-000112
    Q3 2021Quarterly · 2021-09-30ProductMedi Mobility Organ Transport And Jet2,245,000USD0001779128-22-000112
    Q3 2021Quarterly · 2021-09-30ProductShort Distance13,403,000USD0001779128-22-000112
    FY 2021Yearly · 2021-09-30ProductMedi Mobility Organ Transport And Jet26,346,000USD0001779128-21-000025
    FY 2021Yearly · 2021-09-30ProductOther1,927,000USD0001779128-21-000025
    FY 2021Yearly · 2021-09-30ProductShort Distance22,253,000USD0001779128-21-000025
    Q2 2021Quarterly · 2021-06-30ProductMedimobility Organ Transport And Jet6,500,000USD0001104659-21-105544
    Q2 2021Quarterly · 2021-06-30ProductOther Service730,000USD0001104659-21-105544
    Q2 2021Quarterly · 2021-06-30ProductRoyalty2,000USD0001104659-21-105544
    Q2 2021Quarterly · 2021-06-30ProductShort Distance5,721,000USD0001104659-21-105544
    Q1 2021Quarterly · 2021-03-31ProductMedi Mobility Organ Transport And Jet7,727,000USD0001779128-22-000047
    Q1 2021Quarterly · 2021-03-31ProductOther495,000USD0001779128-22-000047
    Q1 2021Quarterly · 2021-03-31ProductShort Distance1,051,000USD0001779128-22-000047
    FY 2020Yearly · 2020-09-30ProductMedi Mobility Organ Transport And Jet13,476,000USD0001779128-21-000025
    FY 2020Yearly · 2020-09-30ProductOther492,000USD0001779128-21-000025
    FY 2020Yearly · 2020-09-30ProductShort Distance9,466,000USD0001779128-21-000025
    Q2 2020Quarterly · 2020-06-30ProductMedimobility Organ Transport And Jet2,636,000USD0001104659-21-105544
    Q2 2020Quarterly · 2020-06-30ProductOther Service173,000USD0001104659-21-105544
    Q2 2020Quarterly · 2020-06-30ProductRoyalty0USD0001104659-21-105544
    Q2 2020Quarterly · 2020-06-30ProductShort Distance629,000USD0001104659-21-105544
    FY 2019Yearly · 2019-09-30ProductMedi Mobility Organ Transport And Jet5,071,000USD0001779128-21-000025
    FY 2019Yearly · 2019-09-30ProductOther85,000USD0001779128-21-000025
    FY 2019Yearly · 2019-09-30ProductShort Distance26,040,000USD0001779128-21-000025

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.